CEO SUMMARY: For many reasons, including cuts to lab test prices that health insurers pay, narrow networks, and more competition for lab test referrals, a significant number of lab companies are seeking ways to increase market share. These methods include the use of new laboratory test arrangements and innovative strategies for pricing lab tests. But
Tag: laboratory management services
In recent weeks, two different lab transactions were announced. One involved a hospital laboratory management contract and the other was a potential merger of two anatomic pathology lab companies. The first announcement came on October 31, when Lovelace Health System of Albuquerque, New Mexico, released news that it entered into an “inpatient and outpatient laboratory
CEO SUMMARY: Deteriorating finances at many rural hospitals and smaller community hospitals is a growing trend. It is also a new consulting opportunity for local pathologists because financially-strapped hospitals often give their labs inadequate working capital and lack the staff needed to comply fully with state and federal compliance requirements. In Shreveport, Louisiana, Delta Pathology
SINCE MAY 1, 2012, the nation’s largest clinical laboratory company has had a new CEO, who is Stephen H. Rusckowski. The company’s second quarter conference call provided an opportunity to learn more about how he views Quest Diagnostics Incorporated.
Conducted on July 19, the first topic of the call was the financial report. For Q2- 12,
CEO SUMMARY: Established with a unique business plan unseen to date in the lab testing industry, aLabs has already entered into laboratory management services contracts with major health systems in Milwaukee and San Diego. This is an impressive start for a newly-formed company that has no prior experience in clinical laboratory operations. aLabs is recruiting
CEO SUMMARY: In less than 12 months, two big private equity firms have each launched a lab company with the goal of acquiring and/or managing the clinical labs of hospitals and health systems. In the case of aLabs, it has signed one laboratory management services contract with Aurora and Advocate health systems and another similar
TO BROADEN ITS CAPABILITIES in handling laboratory test data, Halfpenny Technologies, Inc., announced the acquisition of Laboratory Management Services (LMS) of Hauppauge, New York, earlier this month.
Halfpenny seems to be particularly interested in the informatics solutions developed by LMS to make it easier for clinical laboratories and pathology groups to report laboratory test data to
CEO SUMMARY: In response to the steep ramp-up in the utilization of genetic and molecular testing, the nation’s largest health insurers are preparing to institute new guidelines for coverage and reimbursement. These will include pre-authorization by physicians, a more effective genetic test coding arrangement for claims submission by laboratories, and implementation of evidence-based medicine (EBM)
In response to the sky-rocketing expenses associated with genetic and molecular testing, health insurers are planning ways to control both utilization and the prices at which these tests are reimbursed. For example, during the past year, Humana began using DNA Direct of San Francisco, California, to pre-authorize expensive genetic and molecular tests, while also advising
Larry Siedlick resigned as CEO of Sunrise Medical Laboratories in Hauppauge, New York, effective June 30. It was 2007 when Siedlick and partner Pat Lanza sold their interest in the laboratory they founded back in 1972 to Sonic Healthcare, Ltd. Siedlick tells THE DARK REPORT that he will be developing two laboratory service companies. One